Background: Increasing physical activity and decreasing sedentary time are cornerstones in the management of type 2 diabetes (T2DM). However, there are few instruments available to measure physical activity in this population. We translated the long version of the International Physical Activity Questionnaire (IPAQ-L) into French and studied its reproducibility and validity in patients with T2DM. Methods: Reproducibility was studied by 2 telephone administrations, 8 days apart. Concurrent validity was tested against pedometry for 7 days during habitual life. Results: One-hundred forty-three patients with T2DM were recruited (59% males; age: 60.9 ± 10.5 years; BMI: 31.2 ± 5.2 kg/m 2 ; HbA1c: 7.4 ± 1.2%). Intraclass correlation coefficients (95% CI) for repeated administration (n = 126) were 0.74 (0.61-0.83) for total physical activity, 0.72 (0.57-0.82) for walking, and 0.65 (0.51-0.78) for sitting time. Total physical activity and walking (MET-min·week -1 ) correlated with daily steps (Spearman r = .24 and r = .23, respectively, P < .05). Sitting time (min·week -1 ) correlated negatively with daily steps in women (r = -0.33; P < .05). Conclusion: Our French version of the IPAQ-L appears reliable to assess habitual physical activity and sedentary time in patients with T2DM, confirming previous data in nonclinical populations.
In line with guidelines for the general population, physical activity is recommended in the medical care of patients with type 2 diabetes mellitus (T2DM). 1 Increased physical activity is associated with improved glycemic control 2 and decreased cardiovascular mortality 3, 4 in patients with T2DM. Another important concept is the limitation of sedentary time, which represents the duration of activities that expend very little energy above resting metabolic rate (eg, sitting or screen viewing). 5 Improved assessment of physical activity and sedentary time in a free-living environment is needed to better understand the relations between movement and metabolic health, and to measure the effectiveness of interventions. 6 Available methods include behavioral observations, questionnaires, physiological markers such as heart rate, calorimetry, and motion sensors. 7, 8 Questionnaires are unique in that they provide information on the context in which physical activity is performed. 9 There is observational evidence that physical activity in patients with T2DM is lower compared to healthy populations. Self-reported data indicate that the majority of patients with T2DM do not engage in regular physical activity, with a rate significantly below national norms. 10 Consistent data have also been obtained with pedometry. 11 There is also experimental evidence that patients with T2DM perceive a harder effort during exercise than nondiabetic subjects. 12 Although this justifies specific validation, few questionnaires have been tested in subjects with T2DM. A significant correlation between daily steps in patients with T2DM and the physical activity scale of the short-form-36 was documented. 13 One questionnaire made available in recent years is the IPAQ (International Physical Activity Questionnaire). 14 This questionnaire was developed so that it could be translated and adapted to various cultural settings. 14 The long version of the IPAQ (IPAQ-L) is a last 7-day recall questionnaire assessing domain specific physical activity (at work, during leisure time, doing chores, for transport) and sedentary time (sitting time and time traveling in a motor vehicle). Since the original development work in a general population 18 to 65 years of age, 14 there have been many studies replicating reliability and validity testing of the IPAQ-L in specific populations and minority subgroups [14] [15] [16] [17] [18] [19] [20] [21] [22] using pedometry, 17, 18, 21, 22 accelerometry, 14, 15, 20, 23, 24 or measurement of cardiorespiratory fitness. 19, 24 Apart from one study, 19 significant intra class coefficients (ICC) were reported (0.26-0.55).
With the aim of having an instrument available for physical activity assessment in patients with T2DM, the objective of the current study was to investigate the reproducibility and validity of a French version of the IPAQ-L in such patients.
Methods

The Long Version of the IPAQ
The IPAQ-L comprises 27 items and investigates 4 physical activity domains (work, leisure, chores, transport) as well as time spent sitting as a proxy for sedentary behavior. 14 Physical activity is reported as a continuous score, by domain, by intensity of physical activity (moderate or vigorous), or for walking. Physical activity energy expenditure is calculated according to the following formula (in MET-min·week -1 ): number of days spent doing the activity × average duration of the activity per day × energy cost of the activity. The energy cost of an activity is expressed in MET (Metabolic Equivalent Task). A MET is the ratio of the energy expenditure during a given activity divided by the resting energy expenditure. 25 The following MET values were drawn from the scoring protocol: 3.3 for walking, 4 for moderate intensity physical activity, 8.0 for vigorous physical activity, 6.0 for cycling, 5.5 for vigorous physical activity in the garden or yard, and 3.0 for domestic activities. 26 Three levels of physical activity are proposed in a categorical score: (i) low (category 1) level: individuals who have not met the criteria for categories 2 or 3; (ii) moderate (category 2) level: any 1 of the following 3 criteria: ≥3 days of vigorous activity of at least 20 min/ day, or ≥5 days of moderate-intensity activity or walking of at least 30 min/day, or ≥5 days of any combination of walking, moderate-intensity or vigorous intensity activities achieving at least 600 MET-min·week -1 ; (iii) high (category 3) level: this is reached with any of the following 2 criteria: vigorous-intensity activity on at least 3 days and accumulating at least 1500 MET-min·week -1 , or ≥7 days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum of 3000 MET-min·week -1 .
French Translation
The IPAQ-L was translated into French and adapted following guidelines provided by the IPAQ committee. The IPAQ-L was translated from the English version by 2 independent translators, to obtain a consensual version. This first French version was back translated into English by 2 native English speaking translators, and the second English version was compared with the original English version to check that the meaning of the questions remained the same. A pilot testing of the French IPAQ-L (in 20 patients with T2DM from Tours Hospital including low and middle education levels or social class) was performed to improve the wording to obtain the final version. Pilot testing led to minor alterations in the wording of questions (mainly syntax changes) without any alteration in meaning. The final version of the questionnaire is available at www.ipaq.ki.se.
Study Design
This prospective observational study was carried out between April 2008 and December 2008 in 143 patients with T2DM without cognitive impairment and able to walk at least 100 m. Patients had 1 visit and 2 phone calls 1 week apart.
Initial Visit. During the initial visit, data collected from medical records included: age, sex, measured weight, height, waist circumference, duration of diabetes since diagnosis, last glycated hemoglobin (HbA1c) value, and medications oral antidiabetic drugs and/or insulin).
Each patient was provided with a pedometer (model ix034327, 45 × 35 × 20 mm, attached to the hip with a belt clip) and with a diary so that they could record the number of steps walked each day. Nurses specialized in diabetology showed the patients how to operate the pedometer and made the telephone appointments with the patient. They also tested the accuracy of the pedometers against steps counted by direct observation during a walking trial. A recording between 90% and 100% of the directly observed number of steps was required to start the study. The pedometer was worn during waking hours. No specific physical activity counseling was given.
First Phone Call. Included patients were contacted by phone for the first administration of the IPAQ-L by a research assistant on the evening of the day of their hospital visit. The use of the pedometer began the next day, with the patient recording the number of steps in his/her diary every day.
Second Phone Call. After 7 consecutive days of recording, the patient was contacted by phone again to collect the pedometer data and to carry out the second administration of the IPAQ-L. The research assistant also asked whether physical activity during the week preceding the first IPAQ-L administration had been very different from physical activity during the week preceding the second (eg, working week versus holidays). If the answer was yes, the case was removed from the reproducibility analysis.
Ethical Issues
The study was approved by the local ethics committee to be carried out within the usual care of subjects with T2DM followed as outpatients at the diabetes clinic.
Statistics
The data are presented as means ± standard deviation (SD) and as median and interquartile range for normally and nonnormally distributed data, respectively. The first and second IPAQ-L were compared to assess reproducibility. The second IPAQ-L and pedometry data (pertaining to the same time period for physical activity assessment) were compared to assess concurrent validity. Reproducibility was studied with the intraclass correlation coefficient (ICC). The 95% confidence intervals (95% CI) of the ICC were estimated by bootstrap analysis. 27 Reproducibility was also assessed using the Kappa coefficient for classification of physical activity into categories 1, 2, or 3. 28 The Kappa coefficient ranges from -1 (total discordance) to a possible maximum value of 1 (perfect agreement). If "I do not know" or "refused" were coded in any of the IPAQ-L items, the subject was removed from the analysis, as recommended. 26 Concurrent validity was studied with the Spearman correlation coefficient between the mean number of daily steps (pedometry), total physical activity (min·week -1 and MET-min·week -1 ), walking (MET-min·week -1 ), sitting time (min·week -1 ), and transport duration (min·week -1 ). A minimum of 4 days of pedometry was required for the correlation analysis. Subgroup analyses were performed according to gender, age, and whether subjects had a job or did any unpaid work outside their home.
All analyses were carried out with SAS software (Version 9.1 of SAS system for Windows; SAS Institute Inc., Cary, NC).
Results
One-hundred forty-three patients were included. Their characteristics are shown in Table 1 . Two subjects did not take part in the study of concurrent validity because they wore the pedometer for less than 4 days. One-hundred twenty-six patients took part in the analysis of reproducibility. Among the 17 participants who did not take part in this analysis, 2 answered only the second questionnaire, and the others declared they had very different activities during the 2 weeks investigated by the first and second IPAQ-L. Table 2 shows the results of the administrations of the IPAQ-L. Table 3 shows the distribution of daily steps walked in categories 1, 2, and 3 of the IPAQ-L (drawn from the second administration of the questionnaire). Most patients were classified as very active (category 3) by the IPAQ-L, and only a small proportion was regarded as inactive (category 1). Whereas most patients who walked at least 10,000 steps/day were classified in category 3 of the IPAQ-L, this category also comprised patients who walked less than 10,000 steps/day. Whereas 31/52 patients >65 years of age (58/87 patients <65 years of age) were classified in category 3 of the IPAQ, only 3/31 (22/58 patients <65 years of age) walked over 10,000 steps/day. Note. The initial number of patients studied was 143. For each line, observations are missing because of incomplete data collection (i.e. subjects who did not answer 1 or several items of the IPAQ). Note. There are 2 missing observations for the steps/day variable (2 subjects did not wear the pedometer as required). There are 2 missing observations for the IPAQ category variable (2 subjects had an incomplete questionnaire that did not allow for calculation of total physical activity score). Table 5 shows the correlations between pedometry and the IPAQ-L. Total physical activity and walking (MET-min·week -1 ) measured by the IPAQ-L correlated positively with pedometry (steps/day) in the whole population. Sitting time and duration of motorized transport both correlated negatively with pedometry in the following subgroups: women and subjects declaring no job/ unpaid work outside home. There was no correlation between total physical activity score (MET-min·week -1 ) and body mass index (BMI) (r = .05; P = .5).
Discussion
The French translation of the IPAQ-L had acceptable reproducibility and concurrent validity when compared with pedometry in patients with T2DM. The mean of 7110 steps/day observed in our study is consistent with the calculated mean value of 6342 steps/day from previous studies using waist-mounted instruments in patients with T2DM. 29 The median values for total physical activity were 3705 and 3623 MET-min·week -1 for the first and second administrations of the IPAQ-L, respectively. Although no comparison is available in patients with T2DM, these results are similar to the 3120 MET-min·week -1 found in healthy adults with the Swedish IPAQ-L. 24 The IPAQ-L appears to be reproducible for all intensities of physical activity, with an ICC of 0.74 for total physical activity. This is within the range of values for the original validation of the IPAQ-L (0.46-0.96). 14 The IPAQ-L was found to be reproducible in the work, domestic, leisure, and sedentary domains (ICC 0.54-0.73). Only 2 previous studies reported reproducibility in each of these physical activity domains. 20, 22 The concurrent validity of the IPAQ-L has previously been examined against accelerometry, 14, 15, 20, 23, 24 pedometry 17, 18, 21, 22 (Table 6 ), or cardiorespiratory fitness. 19 The correlation found in our study against pedometry for concurrent validity of the IPAQ-L (total physical activity r = .24) is in accordance with the correlations obtained against accelerometry in healthy subjects by Craig et al. 38) . 20 In the current study, there was no significant correlation between total physical activity or walking and pedometry in patients > 65 years of age. This could be a limitation of the questionnaire in this age-range, but a lack of statistical power cannot be ruled out. This also raises the question of the translation between self-declared physical activity and number of steps. Whereas 30 min of moderate-intensity walking translates to approximately 3000 steps in young and ostensibly healthy subjects in laboratory conditions, 30 comparable data are not available for the elderly.
We did not study the concurrent validity of the IPAQ-L within each domain. Two studies showed positive correlations between physical activity at work and daily steps (r = .24), 17 or physical activity diaries (r = .64). 23 On the other hand, no correlation between physical activity at work and accelerometry was found in another study with smaller sample size (n = 53). 20 A positive correlation between leisure-time physical activity and the reference method (r = .20-.63) was also documented in these studies. 17, 20, 23 The concurrent validity for domestic physical activity is more prone to controversy. Indeed, the validity was confirmed in one study (r = .47) 23 but not in a population of 1239 people. 17 However, the latter study was the only one to use pedometry.
In contrast to accelerometry, pedometry does not allow direct measurement of sedentary time. Nevertheless, sitting time and duration of motorized transport both correlated negatively with pedometry in the subgroups of women and subjects declaring no job/unpaid work outside the home. Consistent with our results, negative correlations between pedometry and sitting time evaluated by the IPAQ-L have already been documented. 17, 21 These results are different from other reports: De Cocker et al found a weak positive correlation between sitting time and pedometry (r = .18), 17 Two explanations are possible for the surprising finding that IPAQ-L category 3 had a similar number of subjects with < 5000 and > 10,000 steps/day. First, overreporting is an inherent limitation of validity when using physical activity questionnaires, 31 especially in obese subjects. 32 It is also possible that patients with T2DM bias their reported physical activity to appear compliant with recommendations for diabetes control. Second, physical activity can be underestimated by pedometry, when activities do not involve any walking (swimming, cycling, or static activities with upper limb movements). Of note, when compared with patients < 65 years of age, patients > 65 years of age were more frequently classified in IPAQ category 3 despite recordings below 10,000 steps/day. This raises the important issue of knowing how the selfdeclared physical activity translates into MET values in older adults. Shortness of breath and perceived exhaustion may appear at lower MET values (ie, less movement and fewer steps in older subjects). This would be responsible for an overestimation of physical activity with the IPAQ. This is consistent with the finding that accelerometry threshold counts for vigorous physical activity are lower in middle-aged to old adult patients with T2DM when compared with younger healthy subjects. 33 There are several limitations to this study. Pedometers do not measure the metabolic cost of physical activity that is supposed to be assessed by the IPAQ-L. Whereas pedometry is an objective tool, able to give acceptable evaluations of walking and moderate intensity physical activity, 11 it underestimates vigorous physical activity and does not measure physical activity associated with upper limb movement or isometric exercises. 7 In addition, there are situations, such as water-based activities, where pedometry cannot be used. Recruitment of patients with T2DM through outpatient hospital care could have selected a nonrepresentative sample of the French diabetic population. However, apart from age (4 years younger), the overall features (sex ratio, BMI, HbA1c) were similar to those reported in patients with T2DM from the French ENTRED survey 2007-2010. 34 A limitation for objective data collection in our study is the fact that patients were not blinded to pedometry data (pedometers were not sealed) and recorded step data themselves. From a recent review, it seems that most published pedometry-related studies do not use sealed pedometers. 35 In conclusion, this study shows that the French version of the IPAQ-L is reproducible and valid for the evaluation of physical activity in French adults with T2DM. This justifies its continued use in physical activity observational studies.
